Long‐term success and influencing factors of regenerative surgery for intra‐bony defects: A retrospective cohort study
Journal of Periodontology · 2025
DOI: 10.1002/jper.23-0701 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Periodontology, 2025. Verfasst von Yan Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Cen…. Hauptthemen laut MEDLINE: Guided Tissue Regeneration, Periodontal, Alveolar Bone Loss. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Peking University School and Hospital of Stomatology, Beijing, China, the National Key R&D Program of China, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The composite outcome measure (COM) more comprehensively assesses the clinical efficacy of regenerative surgery than a single probing measurement. We aimed to assess long‐term success defined by the COM (clinical attachment level [CAL] gain of ≥3 mm and postsurgery probing pocket depth [PPD] ≤ 4 mm) and influencing factors of regenerative surgery using bone substitutes and resorbable collagen membrane (RM) for intra‐bony defects (IBDs).
Methods
We retrospectively collected data from patients who underwent regenerative surgery using deproteinized bovine bone mineral (DBBM) and RM for IBDs. CAL and PPD values were compared at baseline (preoperative), 1 year (short‐term), and at the last follow‐up (5–10 years). Multivariate logistic regressions were performed to identify factors influencing COM‐based long‐term success.
Results
Eighty‐one defects in 75 teeth of 33 patients who completed follow‐up (6.5 ± 1.4 years) were included. One tooth was lost. All defects with complete follow‐up exhibited long‐term average CAL gain (3.00 ± 2.00 mm, 95% confidence interval [CI]: 2.56–3.44 mm, p < 0.001) and PPD reduction (2.06 ± 1.91 mm, 95% CI: 1.64–2.49 mm, p < 0.001). Long‐term success was achieved in 38.8% of IBDs. CAL and PPD values were comparable between 1 year and the last follow‐up. Logistic regression analyses revealed that male sex (odds ratio [OR] = 0.23, 95% CI: 0.07–0.75) and bleeding on probing (BOP) during supportive periodontal therapy (OR = 0.96, 95% CI: 0.94–0.99) were risk factors for long‐term success.
Conclusions
Regenerative surgery with DBBM and RM for IBDs can achieve some degree of long‐term success defined by COM. However, within this study's limitations, male sex and higher BOP incidence postoperatively are negatively associated with optimal long‐term success. Clinical trial number ChiCTR2300069016.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral B…
ORCID-Profile: Yan Huang, Xiangying Ouyang
Förderung
- Peking University School and Hospital of Stomatology, Beijing, China
- the National Key R&D Program of China
- the National Natural Science Foundation of China
Zitieren
APA
Huang, Y., Ouyang, X., Liu, B., Liu, J., Liu, W., & Xie, Y. (2025). Long‐term success and influencing factors of regenerative surgery for intra‐bony defects: A retrospective cohort study. Journal of Periodontology. https://doi.org/10.1002/jper.23-0701
Vancouver
Huang Y, Ouyang X, Liu B, Liu J, Liu W, Xie Y. Long‐term success and influencing factors of regenerative surgery for intra‐bony defects: A retrospective cohort study. Journal of Periodontology. 2025. doi:10.1002/jper.23-0701
BibTeX
@article{Huang2025,
author = {Huang, Yan and Ouyang, Xiangying and Liu, Bei and Liu, Jianru and Liu, Wenyi and Xie, Ying},
title = {Long‐term success and influencing factors of regenerative surgery for intra‐bony defects: A retrospective cohort study},
journal = {Journal of Periodontology},
year = {2025},
doi = {10.1002/jper.23-0701}
}
EUVIMED